Latest period
$135B
YoY change
-0.9%
5Y CAGR
-2.3%
Peak year (FY2020)
$151B
Latest annual
$134B
Total Assets history chart for AbbVie (ABBV) from 2016 to 2025
Latest: $134B
Total Assets growth chart for AbbVie (ABBV) from 2016 to 2025
Latest: -0.9%
Total Assets history table for AbbVie (ABBV) from 2010 to 2025
| FY2025 | $134B | -0.9% | -$1.2B | ||
| FY2024 | $135B | +0.3% | +$450M | ||
| FY2023 | $135B | -2.9% | -$4.09B | ||
| FY2022 | $139B | -5.3% | -$7.72B | ||
| FY2021 | $147B | -2.7% | -$4.04B | ||
| FY2020 | $151B | +69.0% | +$61.5B | ||
| FY2019 | $89.1B | +50.1% | +$29.8B | ||
| FY2018 | $59.4B | -16.2% | -$11.4B | ||
| FY2017 | $70.8B | +7.1% | +$4.69B | ||
| FY2016 | $66.1B | +24.6% | +$13B | ||
| FY2015 | $53.1B | +92.8% | +$25.5B | ||
| FY2014 | $27.5B | -5.8% | -$1.69B | ||
| FY2013 | $29.2B | +8.1% | +$2.19B | ||
| FY2012 | $27B | +38.4% | +$7.49B | ||
| FY2011 | $19.5B | -7.6% | -$1.61B | ||
| FY2010 | $21.1B | — | — |
- FY2025$134B-0.9%
- FY2024$135B+0.3%
- FY2023$135B-2.9%
- FY2022$139B-5.3%
- FY2021$147B-2.7%
- FY2020$151B+69.0%
- FY2019$89.1B+50.1%
- FY2018$59.4B-16.2%
- FY2017$70.8B+7.1%
- FY2016$66.1B+24.6%
- FY2015$53.1B+92.8%
- FY2014$27.5B-5.8%
- FY2013$29.2B+8.1%
- FY2012$27B+38.4%
- FY2011$19.5B-7.6%
- FY2010$21.1B—
Total Assets values are taken from AbbVie's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's latest reported total assets is $135B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, AbbVie (ABBV) reported total assets of $134B – edged down 0.9% year-over-year.
AbbVie total assets has contracted on net over the period, with a -2.3% compound annual growth rate over 2020–2025 (5 years).
Between 2020 and 2025, AbbVie total assets declined 11.0%, falling from $151B to $134B.
The highest annual total assets of $151B was reported in 2020. The lowest in the available history was $19.5B in 2011.
AbbVie Total Assets by Year
AbbVie Total Assets 2025: $134B
AbbVie posted total assets of $134B in 2025, edged down 0.9% below 2024.
AbbVie Total Assets 2024: $135B
In 2024, AbbVie reported total assets of $135B, edged up 0.3% from 2023.
AbbVie Total Assets 2023: $135B
AbbVie total assets in 2023 was $135B, edged down 2.9% below 2022.
AbbVie Total Assets 2022: $139B
2022's total assets for AbbVie came in at $139B, declined 5.3% below 2021.
AbbVie Total Assets 2021: $147B
AbbVie total assets in 2021 was $147B.
See more financial history for AbbVie (ABBV).
Sector peers by Total Assets
Healthcare peers of AbbVie (ABBV), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $114B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $114B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on ABBV
Market Cap — 10 rounds, every one of them ABBV against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.